000 | 01927 a2200457 4500 | ||
---|---|---|---|
005 | 20250513224155.0 | ||
264 | 0 | _c20001228 | |
008 | 200012s 0 0 eng d | ||
022 | _a0363-6135 | ||
024 | 7 |
_a10.1152/ajpheart.2000.279.6.H2658 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHu, K | |
245 | 0 | 0 |
_aEvidence for functional role of epsilonPKC isozyme in the regulation of cardiac Ca(2+) channels. _h[electronic resource] |
260 |
_bAmerican journal of physiology. Heart and circulatory physiology _cDec 2000 |
||
300 |
_aH2658-64 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_a3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium Channel Agonists _xpharmacology |
650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
650 | 0 | 4 |
_aCalcium Channels, L-Type _xmetabolism |
650 | 0 | 4 |
_aEnzyme Activators _xpharmacology |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aIndoles _xpharmacology |
650 | 0 | 4 |
_aIsoenzymes _xantagonists & inhibitors |
650 | 0 | 4 |
_aMaleimides _xpharmacology |
650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
650 | 0 | 4 |
_aMuscle Fibers, Skeletal _xenzymology |
650 | 0 | 4 |
_aMyocardium _xcytology |
650 | 0 | 4 |
_aNisoldipine _xpharmacology |
650 | 0 | 4 | _aPatch-Clamp Techniques |
650 | 0 | 4 |
_aPeptides _xpharmacology |
650 | 0 | 4 |
_aProtein Kinase C _xantagonists & inhibitors |
650 | 0 | 4 | _aProtein Kinase C-epsilon |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
700 | 1 | _aMochly-Rosen, D | |
700 | 1 | _aBoutjdir, M | |
773 | 0 |
_tAmerican journal of physiology. Heart and circulatory physiology _gvol. 279 _gno. 6 _gp. H2658-64 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajpheart.2000.279.6.H2658 _zAvailable from publisher's website |
999 |
_c11028847 _d11028847 |